EntrezGene:26054

Symbol:	SENP6
Description:	SUMO1/sentrin specific peptidase 6
Synonyms:	SSP1, SUSP1
Species:	Human (Homo sapiens)
Xrefs:	EntrezGene:26054 HGNC:20944 MIM:605003 Ensembl:ENSG00000112701 HPRD:05417 Vega:OTTHUMG00000015060
Associated motifs:	NA
Transcripton Factor?:	No

TSS regions

---

Copy Excel CSV PDF

Show 102550All entries

Search:

Hg19::chr6:76311568..76311623,+	p1@SENP6
Hg19::chr6:76311636..76311651,+	p4@SENP6
Hg19::chr6:76311687..76311701,+	p5@SENP6
Hg19::chr6:76311707..76311718,+	p7@SENP6
Hg19::chr6:76311736..76311754,+	p2@SENP6
Hg19::chr6:76311773..76311787,+	p3@SENP6
Hg19::chr6:76311806..76311824,+	p6@SENP6
Hg19::chr6:76311857..76311868,+	p11@SENP6
Hg19::chr6:76311956..76311965,+	p13@SENP6
Hg19::chr6:76311970..76311977,+	p14@SENP6
TSS peak ID	Short_description

Showing 1 to 10 of 14 entries

Previous12Next

View on UCSC genome browser

---

Mouse over to see Genome browser image, Click image to go to Genome browser

TSS expression

---

Copy Excel CSV PDF

Search:

Sample	p1@SENP6	p2@SENP6	p3@SENP6	p4@SENP6	p5@SENP6

Sample	p1@SENP6	p2@SENP6	p3@SENP6	p4@SENP6	p5@SENP6
lung, fetal, donor1.CNhs11680.10068-101I5	83.63	8.65	4.56	5.50	3.93
pituitary gland, adult, donor10252.CNhs12229.10162-103A9	62.61	5.24	3.41	4.10	2.50
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6	62.34	0.75	0.00	2.56	0.15
smooth muscle, adult, pool1.CNhs11755.10048-101G3	60.06	2.70	2.45	3.19	3.43
uterus, adult, pool1.CNhs11676.10100-102D1	58.43	5.38	2.69	2.44	2.08
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5	58.32	1.62	3.78	3.24	2.16
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8	57.58	6.11	8.96	5.97	1.42
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3	56.04	0.89	1.78	0.89	0.89
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8	55.12	2.06	2.88	1.65	1.65
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3	53.90	2.89	0.96	0.96	1.92
pineal gland, adult, donor10252.CNhs12228.10160-103A7	53.81	3.03	1.01	2.02	2.35
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2	52.35	0.26	0.51	1.02	0.38
CD4+ T Cells, donor1.CNhs10853.11225-116C1	52.32	0.00	0.79	1.77	0.00
Neutrophils, donor3.CNhs11905.11390-118C4	52.22	1.66	2.49	4.97	1.24
cerebellum, adult, donor10252.CNhs12323.10166-103B4	51.64	5.42	3.87	2.76	2.10
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5	51.28	4.50	2.65	2.65	2.74
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3	51.27	3.42	0.57	3.42	1.14
CD8+ T Cells, donor1.CNhs10854.11226-116C2	50.60	1.01	0.40	4.44	0.60
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7	50.51	1.67	0.71	3.34	1.43
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5	50.45	0.80	3.20	2.40	1.60
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4	50.24	1.32	0.00	1.98	0.00
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9	49.61	0.00	0.95	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8	49.38	0.96	0.00	0.96	0.32
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9	48.99	2.59	2.16	1.30	1.58
cervix, adult, pool1.CNhs10618.10013-101C4	48.71	3.54	2.77	4.39	2.46
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2	48.17	0.76	3.82	4.59	3.06
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9	47.79	1.28	1.28	0.85	0.00
cerebellum - adult, donor10196.CNhs13799.10173-103C2	47.30	7.63	3.05	6.10	0.00
Mast cell, donor3.CNhs12593.11566-120D9	46.98	5.91	2.31	2.45	2.74
Mast cell, donor2.CNhs12594.11565-120D8	46.03	7.67	4.98	2.90	4.35
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8	45.98	1.15	1.72	1.15	1.15
CD8+ T Cells, donor3.CNhs11999.11383-118B6	45.91	1.01	0.43	2.75	0.29
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4	45.79	0.72	1.91	3.58	0.95
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9	45.62	0.95	2.85	1.90	0.00
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4	45.58	0.00	1.30	1.30	0.65
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4	44.98	6.83	6.20	4.77	1.59
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7	44.87	1.45	1.45	2.48	1.86
vagina, adult.CNhs12854.10204-103F6	43.94	5.33	2.66	4.66	4.66
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1	43.87	0.66	3.99	1.99	1.33
stomach, fetal, donor1.CNhs11771.10062-101H8	43.82	4.38	5.84	2.92	0.73
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1	43.74	6.46	2.98	6.46	6.34
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1	43.64	1.01	2.54	6.09	0.51
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1	43.57	1.18	0.47	2.13	0.47
Natural Killer Cells, donor1.CNhs10859.11230-116C6	43.35	1.38	1.77	3.55	1.18
Mast cell, donor4.CNhs12592.11567-120E1	43.30	5.68	2.40	2.52	2.65
CD19+ B Cells, donor3.CNhs12354.11705-123B4	43.20	0.76	0.76	0.76	1.15
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2	43.15	4.66	2.55	2.00	3.11
aorta, adult, pool1.CNhs11760.10052-101G7	43.04	2.99	1.99	1.79	2.59
CD4+ T Cells, donor2.CNhs11955.11306-117C1	42.84	0.39	0.00	1.97	0.00
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2	42.69	1.49	2.13	2.13	1.71
Eosinophils, donor3.CNhs12549.12246-129H5	42.66	3.88	0.00	3.88	0.00
bladder, adult, pool1.CNhs10616.10011-101C2	42.52	1.97	0.99	1.58	0.99
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7	42.05	0.55	0.55	2.18	1.09
heart - pulmonic valve, adult.CNhs12856.10206-103F8	41.71	2.52	2.06	1.83	2.98
thalamus, adult, donor10252.CNhs12314.10154-103A1	41.58	3.62	1.86	1.65	2.48
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4	41.50	0.65	1.95	1.95	1.30
dura mater, adult, donor1.CNhs10648.10041-101F5	41.39	3.79	3.73	2.97	1.58
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8	41.23	1.49	0.37	4.83	0.00
CD8+ T Cells, donor2.CNhs11956.11307-117C2	40.92	1.07	0.00	2.41	0.00
ovary, adult, pool1.CNhs10626.10020-101D2	40.76	1.88	1.81	2.41	1.58
colon, adult, pool1.CNhs10619.10014-101C5	40.69	2.12	1.59	2.39	1.86
uterus, fetal, donor1.CNhs11763.10055-101H1	40.69	2.85	4.88	1.22	4.48
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9	40.62	2.39	3.58	1.19	0.00
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7	40.22	5.11	1.92	1.28	2.55
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3	40.18	3.77	4.08	2.83	1.57
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7	39.75	0.21	0.64	3.19	0.43
parietal lobe, adult, donor10252.CNhs12317.10157-103A4	39.48	3.51	1.65	2.69	0.83
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7	39.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1.CNhs10852.11224-116B9	39.33	1.66	3.32	2.22	0.00
penis, adult.CNhs12850.10200-103F2	39.20	3.47	3.47	2.48	0.99
prostate, adult, pool1.CNhs10628.10022-101D4	39.09	3.38	1.57	2.83	2.35
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8	38.97	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3.CNhs12001.11387-118C1	38.89	2.18	1.03	3.34	1.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7	38.68	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252.CNhs12319.10161-103A8	38.61	3.15	1.37	1.64	2.88
substantia nigra, adult, donor10252.CNhs12318.10158-103A5	38.56	6.16	3.87	1.43	2.72
thymus, adult, pool1.CNhs10633.10027-101D9	38.56	0.65	0.78	1.81	0.32
optic nerve, donor1.CNhs13449.10277-104E7	38.55	2.86	2.86	0.00	0.00
thymus, fetal, pool1.CNhs10650.10043-101F7	38.42	1.24	2.05	1.18	1.24
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4	38.32	1.14	2.29	3.43	0.00
vein, adult.CNhs12844.10191-103E2	38.24	1.61	2.42	1.81	0.60
Neutrophils, donor1.CNhs10862.11233-116C9	38.20	2.25	3.00	2.25	0.75
trachea, fetal, donor1.CNhs11766.10058-101H4	37.92	4.66	2.99	2.00	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2	37.81	0.00	0.15	1.19	0.15
seminal vesicle, adult.CNhs12851.10201-103F3	37.68	1.69	0.85	1.69	2.54
CD34+ Progenitors, donor2.CNhs12205.11625-122B5	37.55	8.41	3.92	5.04	2.80
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5	37.48	1.25	1.25	0.00	0.00
hippocampus, adult, donor10252.CNhs12312.10153-102I9	37.32	3.68	2.72	1.77	1.63
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6	37.26	4.34	3.57	3.96	4.59
CD4+ T Cells, donor3.CNhs11998.11382-118B5	37.01	0.62	0.21	0.82	0.00
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6	36.95	0.82	0.82	1.64	0.00
colon, fetal, donor1.CNhs11780.10070-101I7	36.66	1.83	1.83	3.67	3.67
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6	36.48	0.00	2.38	2.38	3.17
CD19+ B Cells, donor1.CNhs12343.11544-120B5	36.43	1.14	1.14	1.71	1.14
CD14+ Monocytes, donor2.CNhs11954.11305-117B9	36.10	3.01	3.41	1.60	2.81
middle temporal gyrus, donor10252.CNhs12316.10156-103A3	35.81	4.29	2.35	2.90	2.07
pituitary gland - adult, donor10196.CNhs13805.10180-103C9	35.81	7.89	4.25	1.82	6.68
Hepatocyte, donor1.CNhs12340.11523-119I2	35.49	1.27	0.00	1.27	0.00
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6	35.43	3.38	1.75	1.88	2.13
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6	35.14	2.28	1.95	3.25	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4	34.78	0.00	0.27	1.34	0.00
ductus deferens, adult.CNhs12846.10196-103E7	34.72	2.37	0.79	2.76	2.37
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8	34.64	0.00	0.00	1.12	0.00
spinal cord, adult, donor10252.CNhs12227.10159-103A6	34.46	3.27	3.56	2.67	2.67
retina, adult, pool1.CNhs10636.10030-101E3	34.09	3.57	2.50	2.14	2.14
small intestine, adult, pool1.CNhs10630.10024-101D6	33.80	2.24	1.78	1.70	1.78
adipose tissue, adult, pool1.CNhs10615.10010-101C1	33.70	4.40	2.20	2.20	2.64
amygdala, adult, donor10252.CNhs12311.10151-102I7	33.62	3.66	2.67	1.55	2.11
thyroid, fetal, donor1.CNhs11769.10060-101H6	33.55	5.05	4.45	1.41	2.02
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2	33.53	3.38	1.33	1.93	1.69
CD19+ B Cells, donor2.CNhs12352.11624-122B4	33.47	2.35	0.59	2.94	0.00
appendix, adult.CNhs12842.10189-103D9	33.43	2.76	1.66	1.38	0.83
Natural Killer Cells, donor2.CNhs11957.11311-117C6	33.21	1.29	0.86	3.88	1.29
spleen, adult, pool1.CNhs10631.10025-101D7	33.08	2.63	3.20	2.26	1.22
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3	33.06	4.23	1.98	1.59	2.12
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4	32.94	0.84	0.84	1.27	0.00
rectum, fetal, donor1.CNhs11777.10067-101I4	32.87	0.91	3.65	0.91	3.65
throat, fetal, donor1.CNhs11770.10061-101H7	32.85	4.76	3.33	1.43	1.67
hippocampus - adult, donor10196.CNhs13795.10169-103B7	32.60	3.98	0.80	2.39	3.98
heart, fetal, pool1.CNhs10653.10046-101G1	32.38	3.09	4.03	1.61	1.81
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9	32.35	3.30	5.97	3.46	3.46
gastric cancer cell line:AZ521.CNhs11286.10549-107H9	32.30	2.18	3.55	2.41	1.37
heart - tricuspid valve, adult.CNhs12857.10207-103F9	32.30	2.87	4.31	1.44	2.15
occipital cortex, adult, donor10252.CNhs12320.10163-103B1	32.25	2.87	1.92	2.71	2.71
diaphragm, fetal, donor1.CNhs11779.10069-101I6	32.10	4.82	3.21	0.00	4.82
Hepatocyte, donor3.CNhs12626.11684-122I1	31.90	5.32	0.59	2.95	4.14
salivary gland, adult, pool1.CNhs11677.10093-102C3	31.84	2.15	0.43	2.15	2.15
lung, adult, pool1.CNhs10625.10019-101D1	31.72	2.88	1.71	2.35	1.71
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7	31.71	2.16	1.94	1.51	0.86
Reticulocytes, biol_rep1.CNhs13552.11931-125I5	31.57	1.32	0.44	2.19	1.97
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1	31.37	0.51	0.25	0.76	0.25
putamen, adult, donor10196.CNhs12324.10176-103C5	31.27	2.83	1.89	1.57	1.10
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1	31.20	3.72	0.81	1.13	2.42
breast, adult, donor1.CNhs11792.10080-102A8	31.17	2.90	0.72	0.00	3.62
gall bladder, adult.CNhs12848.10198-103E9	30.95	2.13	1.71	1.71	3.42
parotid gland, adult.CNhs12849.10199-103F1	30.70	2.19	2.19	1.10	1.64
pons, adult, pool1.CNhs10640.10033-101E6	30.52	6.73	4.01	1.56	3.06
Eosinophils, donor2.CNhs12548.12245-129H4	30.31	2.64	1.32	1.32	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7	30.24	0.00	0.34	0.34	0.34
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3	30.24	2.49	1.24	1.66	2.90
corpus callosum, adult, pool1.CNhs10649.10042-101F6	30.20	3.71	3.71	1.75	2.43
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2	30.08	2.51	0.00	5.01	2.51
glioma cell line:GI-1.CNhs10731.10413-106B8	30.05	1.73	2.60	3.47	2.89
Neutrophils, donor2.CNhs11959.11314-117C9	29.92	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5	29.83	0.95	0.00	2.37	0.00
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1	29.82	6.66	4.52	6.55	6.44
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9	29.73	4.87	4.17	2.78	1.74
thyroid, adult, pool1.CNhs10634.10028-101E1	29.72	4.52	3.50	1.91	2.61
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3	29.58	0.44	0.00	0.44	0.44
Reticulocytes, biol_rep2.CNhs13553.11932-125I6	29.54	0.52	2.09	0.78	0.52
Mast cell, donor1.CNhs12566.11563-120D6	29.50	4.14	2.47	1.58	1.94
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5	29.48	1.64	1.64	3.28	1.97
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4	29.41	0.47	1.10	1.26	0.94
small intestine, fetal, donor1.CNhs11773.10064-101I1	29.29	2.62	2.40	1.09	1.75
Cardiac Myocyte, donor1.CNhs12341.11525-119I4	29.26	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3	29.24	2.87	5.16	1.15	0.57
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8	29.10	2.12	2.12	2.65	1.59
salivary acinar cells, donor3.CNhs12812.11773-123I9	29.03	2.07	2.77	0.00	2.77
thalamus - adult, donor10196.CNhs13794.10168-103B6	29.02	4.15	1.66	0.00	0.00
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3	29.00	2.78	2.60	1.22	1.56
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1	28.96	0.98	0.74	1.35	0.86
parietal lobe - adult, donor10196.CNhs13797.10171-103B9	28.90	4.69	1.56	0.00	3.12
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7	28.68	0.33	0.33	3.26	0.00
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1	28.58	1.64	1.41	1.05	1.87
Keratinocyte - oral, donor1.CNhs10879.11251-116E9	28.42	0.93	0.65	0.37	0.56
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5	28.13	2.78	3.71	2.47	2.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7	28.00	1.18	0.71	2.44	1.26
epididymis, adult.CNhs12847.10197-103E8	27.96	2.80	2.27	2.10	1.22
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3	27.91	1.89	1.56	1.40	0.74
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3	27.84	1.45	2.42	2.03	0.58
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9	27.82	2.87	0.57	1.15	2.87
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8	27.82	1.28	1.28	0.86	0.00
lymph node, adult, donor1.CNhs11788.10077-102A5	27.79	1.49	0.50	0.99	0.50
CD14+ Monocytes, donor3.CNhs11997.11381-118B4	27.78	2.60	2.82	1.95	1.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6	27.75	0.78	1.78	2.35	1.21
esophagus, adult, pool1.CNhs10620.10015-101C6	27.74	1.65	1.07	1.45	1.55
trachea, adult, pool1.CNhs10635.10029-101E2	27.68	2.44	1.79	2.65	2.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2	27.66	1.15	1.07	1.30	0.61
parietal lobe, fetal, donor1.CNhs11782.10072-101I9	27.35	2.73	2.73	0.00	0.55
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2	27.32	2.09	3.86	0.64	0.48
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4	27.31	0.87	1.18	1.50	0.79
astrocytoma cell line:TM-31.CNhs10742.10425-106D2	27.31	2.15	4.30	1.02	0.82
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1	27.11	2.36	1.38	1.51	1.18
frontal lobe, adult, pool1.CNhs10647.10040-101F4	27.03	4.05	2.72	1.65	1.27
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1	27.03	1.93	0.00	0.00	0.00
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1	27.01	1.11	2.05	1.36	0.60
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7	26.88	2.86	1.86	1.86	1.86
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4	26.73	1.66	3.96	4.48	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9	26.64	1.46	2.92	1.82	0.73
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7	26.63	0.28	0.69	1.66	1.11
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1	26.62	2.01	0.95	0.95	0.35
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6	26.52	0.62	0.25	0.62	0.62
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4	26.44	0.00	0.38	1.15	0.00
olfactory region, adult.CNhs12611.10195-103E6	26.32	3.39	1.94	1.29	0.81
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6	26.28	2.08	3.23	0.23	1.15
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6	26.21	4.15	4.59	2.18	3.82
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1	26.07	0.86	2.30	1.30	0.58
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9	26.00	0.27	0.27	1.35	0.00
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3	25.90	0.00	1.94	1.29	1.94
colon, adult, donor1.CNhs11794.10082-102B1	25.88	2.99	0.00	1.00	2.99
umbilical cord, fetal, donor1.CNhs11765.10057-101H3	25.81	0.00	4.69	0.00	2.35
throat, adult.CNhs12858.10209-103G2	25.80	2.77	2.56	1.07	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2	25.75	0.17	0.00	1.17	0.33
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7	25.55	7.66	10.22	2.55	0.00
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4	25.51	3.20	3.20	2.17	2.73
testis, adult, pool1.CNhs10632.10026-101D8	25.46	2.27	2.42	2.58	2.05
cerebellum, adult, pool1.CNhs11795.10083-102B2	25.42	3.55	2.07	2.96	1.77
meningioma cell line:HKBMM.CNhs11945.10691-109F7	25.41	0.71	0.94	1.41	1.65
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7	25.39	2.55	1.97	1.51	0.70
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1	25.38	5.64	4.23	0.00	4.23
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9	25.31	3.05	0.44	2.18	2.18
tonsil, adult, pool1.CNhs10654.10047-101G2	25.26	1.48	1.68	0.88	1.08
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7	25.10	8.03	3.01	2.68	3.68
diencephalon, adult.CNhs12610.10193-103E4	25.07	3.28	2.58	1.17	3.28
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3	24.99	1.33	1.33	0.44	1.48
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5	24.93	1.49	1.57	1.22	0.79
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5	24.87	3.69	3.86	3.78	4.02
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6	24.82	1.41	1.87	2.34	0.94
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6	24.64	0.98	2.68	1.10	0.49
heart - mitral valve, adult.CNhs12855.10205-103F7	24.58	1.12	3.07	4.19	1.40
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1	24.53	1.43	1.25	3.22	1.07
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1	24.49	0.83	0.83	5.53	1.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6	24.48	1.51	1.77	1.77	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5	24.42	3.14	4.21	6.19	3.14
hepatoma cell line:Li-7.CNhs11271.10484-107A7	24.41	2.56	2.07	4.82	2.66
kidney, adult, pool1.CNhs10622.10017-101C8	24.35	1.97	2.60	1.58	1.89
spinal cord - adult, donor10196.CNhs13807.10181-103D1	24.34	2.36	2.36	0.98	0.98
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7	24.27	1.41	0.94	2.36	0.94
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5	24.25	1.46	3.58	1.19	0.13
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8	24.20	0.00	3.63	2.42	0.00
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4	24.19	2.02	7.31	2.77	2.27
Basophils, donor2.CNhs12563.12242-129H1	24.18	1.54	1.15	2.30	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5	24.17	0.16	0.00	1.32	0.16
placenta, adult, pool1.CNhs10627.10021-101D3	24.13	3.46	3.64	1.95	2.39
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9	24.12	2.30	2.30	1.15	1.15
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1	24.11	4.73	3.30	2.32	1.70
Sertoli Cells, donor1.CNhs10851.11255-116F4	24.10	0.00	3.21	1.61	1.61
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3	24.07	2.15	1.29	0.43	1.29
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2	24.01	1.71	2.29	0.57	0.86
blood, adult, pool1.CNhs11761.10053-101G8	23.95	7.18	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2	23.91	1.72	1.03	2.58	1.03
submaxillary gland, adult.CNhs12852.10202-103F4	23.85	2.29	1.83	0.46	1.38
kidney, fetal, pool1.CNhs10652.10045-101F9	23.81	3.30	2.89	1.52	1.52
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7	23.74	1.93	1.61	1.29	1.93
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3	23.65	5.91	2.18	2.18	1.24
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7	23.48	5.77	3.38	2.59	5.17
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3	23.44	5.30	1.46	2.12	2.91
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1	23.44	2.83	1.73	1.67	1.67
occipital lobe, fetal, donor1.CNhs11784.10073-102A1	23.44	0.76	1.26	2.02	0.50
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6	23.37	1.51	2.16	2.81	1.51
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8	23.37	3.31	2.63	1.76	0.88
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9	23.23	3.77	1.73	2.51	2.83
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2	23.17	1.72	1.62	1.32	1.92
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2	23.17	0.66	0.99	0.99	0.00
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9	23.16	3.40	1.80	2.08	0.85
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6	23.16	0.96	0.64	1.71	0.32
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7	23.09	3.30	2.97	2.31	2.31
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6	23.02	0.62	1.24	0.99	0.50
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4	22.98	2.40	1.89	2.23	2.40
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1	22.90	0.29	1.47	1.76	0.29
left atrium, adult, donor1.CNhs11790.10079-102A7	22.87	4.29	0.00	0.71	0.71
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8	22.83	2.10	2.10	1.35	0.75
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4	22.68	2.32	1.43	1.07	0.89
occipital cortex - adult, donor10196.CNhs13798.10172-103C1	22.67	1.42	1.42	0.00	1.42
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5	22.63	3.49	1.69	2.70	3.04
medulla oblongata, adult, pool1.CNhs10645.10038-101F2	22.54	3.79	2.17	1.99	1.49
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4	22.51	2.17	1.09	0.54	1.09
left ventricle, adult, donor1.CNhs11789.10078-102A6	22.51	2.65	0.66	0.00	0.66
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7	22.50	3.50	3.10	1.89	3.37
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2	22.45	4.81	3.21	1.60	4.01
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1	22.30	1.47	1.38	1.28	1.77
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2	22.29	4.11	2.35	1.56	1.76
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1	22.23	3.14	2.47	1.57	2.47
b cell line:RPMI1788.CNhs10744.10427-106D4	22.16	1.23	1.48	1.60	0.86
heart, adult, pool1.CNhs10621.10016-101C7	22.09	2.23	0.89	2.23	1.79
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4	22.05	2.90	2.11	1.05	1.67
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2	21.99	3.44	5.79	4.12	1.96
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1	21.98	0.63	1.69	2.11	1.48
testis, adult, pool2.CNhs12998.10096-102C6	21.97	2.14	1.88	2.95	0.80
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9	21.89	3.61	1.29	0.52	1.29
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5	21.88	2.08	1.82	2.86	2.08
skeletal muscle, adult, pool1.CNhs10629.10023-101D5	21.87	2.77	3.59	1.23	2.36
spleen, fetal, pool1.CNhs10651.10044-101F8	21.85	3.35	2.64	1.22	0.97
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4	21.74	2.87	4.08	1.06	1.66
eye, fetal, donor1.CNhs11762.10054-101G9	21.69	1.36	1.13	0.68	1.13
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4	21.68	0.96	0.48	1.77	1.12
salivary acinar cells, donor2.CNhs12811.11772-123I8	21.68	2.22	1.20	2.05	1.71
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1	21.62	0.94	1.72	0.63	0.31
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8	21.60	2.17	1.65	1.45	1.45
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2	21.59	4.14	1.16	1.29	1.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9	21.56	0.55	0.55	1.38	0.00
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7	21.45	1.93	1.10	1.93	1.10
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9	21.38	1.27	1.06	2.54	1.48
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8	21.27	3.54	0.89	1.77	1.77
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4	21.27	1.16	1.86	1.28	1.05
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6	21.26	5.31	0.89	0.00	2.66
tenocyte, donor1.CNhs12639.11763-123H8	21.20	2.60	1.12	0.74	3.35
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2	21.18	4.81	6.74	3.53	3.21
spinal cord, fetal, donor1.CNhs11764.10056-101H2	21.13	2.96	1.27	1.27	1.27
melanoma cell line:COLO 679.CNhs11281.10514-107E1	21.08	2.43	3.18	1.67	1.82
Synoviocyte, donor3.CNhs12050.11440-118H9	21.07	1.32	0.66	0.99	1.32
cerebral meninges, adult.CNhs12840.10188-103D8	21.06	3.07	1.54	2.85	2.19
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1	21.02	3.92	5.33	0.84	1.96
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3	20.97	2.13	1.42	1.78	2.84
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6	20.95	5.81	1.26	2.78	6.56
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3	20.93	2.07	2.58	2.33	1.81
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8	20.92	1.23	3.69	2.46	3.69
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1	20.90	3.71	0.46	2.32	1.39
pineal gland - adult, donor10196.CNhs13804.10179-103C8	20.89	3.21	2.68	0.00	0.54
amygdala - adult, donor10196.CNhs13793.10167-103B5	20.88	5.96	0.00	0.00	0.99
insula, adult, pool1.CNhs10646.10039-101F3	20.84	3.10	2.67	1.88	1.46
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8	20.77	14.06	10.38	3.22	5.88
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7	20.75	1.78	1.58	1.78	1.38
brain, adult, pool1.CNhs10617.10012-101C3	20.69	2.50	1.67	1.48	1.48
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3	20.61	6.18	1.80	3.35	5.93
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4	20.60	0.68	1.37	0.57	0.23
Neural stem cells, donor1.CNhs11063.11275-116H6	20.58	3.05	2.54	2.03	0.25
liver, adult, pool1.CNhs10624.10018-101C9	20.52	3.96	2.20	1.32	1.47
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3	20.47	0.00	0.00	0.00	0.00
tongue, adult.CNhs12853.10203-103F5	20.47	1.09	1.74	1.09	1.31
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7	20.45	1.45	0.73	0.87	1.31
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5	20.43	1.31	6.55	1.05	2.10
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5	20.41	1.62	1.30	0.65	1.62
globus pallidus - adult, donor10196.CNhs13801.10175-103C4	20.41	2.40	2.40	0.00	2.40
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4	20.40	1.12	0.56	1.87	1.68
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2	20.38	3.88	6.79	2.18	1.70
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3	20.38	3.54	2.07	1.46	1.83
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5	20.37	0.56	2.11	0.67	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6	20.33	3.75	3.57	4.49	3.85
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7	20.32	0.84	1.11	2.23	0.56
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7	20.28	2.23	1.24	0.49	1.48
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9	20.27	0.73	0.49	0.49	0.85
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8	20.24	1.43	0.86	0.86	0.86
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3	20.20	3.19	1.13	1.96	2.27
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1	20.17	0.11	0.23	1.59	0.11
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7	20.17	2.50	1.25	0.62	2.29
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3	20.15	4.09	1.57	0.94	5.04
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6	20.15	2.34	1.08	1.08	0.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9	20.00	0.00	0.29	0.29	0.00
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3	19.99	2.35	2.55	1.57	1.27
cervical cancer cell line:ME-180.CNhs11289.10553-107I4	19.94	1.12	1.25	0.84	1.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5	19.92	1.03	1.37	1.72	0.00
parietal lobe, adult, pool1.CNhs10641.10034-101E7	19.91	2.79	2.16	1.46	1.20
skin, fetal, donor1.CNhs11774.10065-101I2	19.91	0.97	1.94	0.49	0.49
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7	19.83	1.80	0.60	0.75	1.50
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2	19.80	3.27	1.73	1.15	2.31
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3	19.80	1.16	11.65	0.00	0.00
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9	19.76	3.20	2.33	2.33	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8	19.73	0.13	0.00	1.41	0.38
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6	19.71	3.77	3.14	1.76	1.76
Hepatocyte, donor2.CNhs12349.11603-120I1	19.66	9.83	2.95	1.97	0.98
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5	19.64	2.13	2.13	0.75	1.63
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8	19.64	2.09	2.79	1.63	0.93
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4	19.58	0.89	0.00	0.00	1.78
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1	19.56	2.55	2.13	0.85	0.85
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5	19.55	0.64	0.64	0.64	0.32
pancreas, adult, donor1.CNhs11756.10049-101G4	19.54	2.34	0.78	0.78	0.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3	19.50	0.11	0.11	1.11	0.22
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2	19.49	1.32	1.58	2.11	0.79
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2	19.46	4.58	2.86	1.14	0.29
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6	19.38	2.91	2.66	1.14	1.01
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4	19.35	0.00	0.53	0.53	0.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3	19.33	1.59	1.59	0.87	0.29
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7	19.32	3.70	3.70	0.82	2.88
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6	19.27	0.00	0.22	1.11	0.00
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9	19.24	2.52	1.37	2.29	3.21
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9	19.23	0.26	1.28	0.77	0.26
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6	19.21	1.35	3.26	0.90	0.67
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9	19.18	1.02	1.36	0.68	0.17
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8	19.16	4.79	3.59	0.00	4.79
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9	19.15	1.01	0.74	1.47	2.21
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6	19.11	2.32	1.36	1.23	3.55
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2	19.07	1.86	0.86	1.72	2.58
amniotic membrane cells, donor2.CNhs12503.12236-129G4	19.01	2.67	1.78	1.78	2.38
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8	18.98	2.11	2.11	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9	18.98	1.53	2.45	3.06	0.31
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9	18.90	2.98	1.79	1.59	1.19
Basophils, donor3.CNhs12575.12243-129H2	18.89	2.48	1.86	0.46	1.08
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9	18.85	2.88	1.11	0.89	1.11
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9	18.85	1.80	3.41	2.60	1.08
tongue, fetal, donor1.CNhs11768.10059-101H5	18.82	2.40	3.76	0.34	0.68
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4	18.79	2.85	1.51	1.96	1.60
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1	18.78	5.98	3.99	4.16	3.99
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9	18.72	1.60	0.91	2.74	0.68
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1	18.69	0.90	0.80	1.80	0.60
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8	18.66	0.58	0.00	1.46	0.00
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9	18.65	1.70	0.85	0.85	1.91
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5	18.65	1.13	1.61	1.61	0.64
Neurons, donor1.CNhs12338.11494-119E9	18.56	3.87	3.09	1.55	2.32
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2	18.46	2.34	1.64	0.93	1.87
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8	18.45	1.28	0.51	3.84	1.02
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6	18.44	1.73	1.15	1.73	0.00
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6	18.39	1.57	2.35	0.78	0.20
mature adipocyte, donor4.CNhs12562.12234-129G2	18.36	3.61	1.97	2.95	2.95
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6	18.32	3.33	8.66	3.00	2.33
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9	18.29	2.37	1.58	2.37	1.58
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5	18.27	2.76	3.45	0.69	1.38
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9	18.27	0.00	0.29	1.47	0.00
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7	18.25	2.17	1.56	1.91	1.91
Neural stem cells, donor2.CNhs11384.11352-117H2	18.22	2.60	1.30	7.81	0.00
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6	18.17	2.78	2.27	1.64	1.77
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4	18.16	6.24	9.65	0.57	3.97
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6	18.11	2.03	1.59	1.30	1.74
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8	18.10	0.70	0.00	0.40	0.80
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3	18.08	1.10	1.83	0.55	0.55
mature adipocyte, donor2.CNhs12559.12232-129F9	18.05	2.76	1.25	0.75	0.50
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4	18.01	2.88	1.44	1.44	2.52
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8	18.01	4.64	2.16	3.13	1.73
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4	17.97	1.43	2.45	1.02	2.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3	17.82	0.13	0.13	0.78	0.26
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7	17.82	0.00	1.19	3.56	0.00
migratory langerhans cells, donor2.CNhs13536.11902-125F3	17.80	1.33	0.80	0.80	0.27
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5	17.80	1.00	1.25	1.25	0.25
tenocyte, donor3.CNhs12641.11768-123I4	17.74	4.33	0.87	0.87	2.60
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3	17.73	1.95	1.65	1.05	1.80
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4	17.63	2.32	1.06	1.37	1.27
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7	17.61	1.35	1.35	0.00	2.71
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3	17.61	1.86	1.52	1.02	0.85
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9	17.59	3.63	4.07	1.74	2.33
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6	17.59	1.14	0.57	0.00	1.70
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1	17.57	0.70	1.41	1.64	1.41
tenocyte, donor2.CNhs12640.11765-123I1	17.56	4.62	0.00	2.77	0.92
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9	17.51	1.42	1.26	1.10	0.47
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9	17.49	3.18	2.86	1.27	4.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7	17.45	1.34	1.51	2.01	1.01
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8	17.45	1.25	2.91	0.83	0.83
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5	17.44	4.36	3.74	1.25	4.36
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4	17.44	1.27	2.43	1.27	1.04
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3	17.43	1.78	1.78	2.13	1.07
salivary acinar cells, donor1.CNhs12810.11771-123I7	17.41	1.66	2.07	1.45	1.24
glioblastoma cell line:A172.CNhs11185.10444-106F3	17.36	1.15	0.94	0.94	0.94
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1	17.35	3.25	1.45	0.72	2.89
Synoviocyte, donor2.CNhs11992.11368-117I9	17.31	2.11	0.42	0.84	1.06
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8	17.29	2.93	0.80	1.06	0.53
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8	17.26	1.18	2.60	0.95	0.71
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6	17.26	1.38	6.21	2.76	3.45
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5	17.24	0.37	0.73	1.10	0.55
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1	17.15	0.55	0.73	0.73	0.18
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4	17.12	4.28	0.00	1.43	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6	17.06	1.37	0.78	1.37	1.37
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1	17.04	2.29	1.27	2.03	3.05
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1	17.03	2.11	1.53	1.06	3.29
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5	17.02	3.81	2.46	0.22	0.45
Cardiac Myocyte, donor3.CNhs12571.11686-122I3	17.01	2.81	1.79	0.64	3.07
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5	17.01	0.50	0.00	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7	17.00	1.76	3.84	2.07	1.87
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9	16.90	2.22	1.94	0.28	1.66
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5	16.88	0.65	3.25	1.62	1.30
mature adipocyte, donor1.CNhs12558.12231-129F8	16.86	2.18	1.63	2.18	1.63
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2	16.85	1.90	0.47	2.14	1.19
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5	16.77	1.80	1.40	0.20	1.80
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8	16.77	0.34	2.01	0.34	0.00
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4	16.73	3.06	3.77	0.94	1.65
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3	16.71	1.23	0.69	0.92	1.08
amniotic membrane cells, donor1.CNhs12502.12235-129G3	16.71	5.01	2.39	3.10	4.30
mesothelioma cell line:ONE58.CNhs13075.10858-111G3	16.71	2.73	0.91	4.56	0.91
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8	16.70	0.96	1.54	0.00	0.77
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7	16.67	4.58	2.00	1.41	2.58
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8	16.66	2.99	1.49	2.14	2.56
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8	16.66	2.87	1.43	0.90	2.15
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1	16.63	0.94	1.53	0.47	0.47
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1	16.61	2.12	1.18	0.71	2.00
Neurons, donor3.CNhs13815.11655-122E8	16.59	2.55	1.91	1.28	1.28
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6	16.57	1.87	3.74	0.80	0.53
occipital pole, adult, pool1.CNhs10643.10036-101E9	16.53	1.59	1.52	1.18	1.11
brain, adult, donor1.CNhs11796.10084-102B3	16.48	2.91	1.94	1.94	2.91
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2	16.45	2.98	1.53	1.45	1.87
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9	16.44	1.90	1.79	1.01	1.79
occipital lobe, adult, donor1.CNhs11787.10076-102A4	16.41	1.64	1.64	0.41	1.44
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8	16.36	1.87	2.04	1.19	2.22
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2	16.31	0.96	0.96	0.69	0.27
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2	16.29	3.97	1.64	1.51	1.09
immature langerhans cells, donor2.CNhs13480.11905-125F6	16.25	3.10	0.00	3.10	3.10
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5	16.24	0.66	0.00	0.33	0.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5	16.24	1.13	0.00	2.48	1.58
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2	16.22	1.14	0.57	1.99	1.71
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9	16.20	3.54	2.36	1.69	4.39
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6	16.20	1.14	1.42	0.85	1.99
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5	16.19	2.75	2.43	1.46	2.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6	16.19	4.50	1.80	1.35	1.80
nasal epithelial cells, donor2.CNhs12574.12227-129F4	16.17	0.00	0.62	4.35	0.00
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1	16.13	1.38	0.83	1.52	1.52
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4	16.08	3.61	1.07	2.14	2.83
Urothelial cells, donor0.CNhs10843.11216-116B1	16.08	3.68	0.46	0.69	2.07
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4	16.08	1.71	3.25	2.05	0.68
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6	16.06	1.69	0.85	0.85	2.54
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5	16.05	1.90	1.37	1.90	1.27
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4	16.05	0.48	0.59	0.36	0.59
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7	16.02	1.53	0.76	1.78	0.25
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8	16.02	1.57	3.40	1.13	1.22
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9	16.01	2.11	1.97	1.12	2.81
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8	16.00	2.22	0.98	1.23	1.97
Melanocyte - dark, donor3.CNhs12570.11663-122F7	16.00	1.65	1.21	0.51	0.38
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4	15.97	1.35	1.11	0.98	1.23
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6	15.96	2.46	1.54	1.07	0.77
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2	15.95	2.66	3.02	1.45	0.73
chorionic membrane cells, donor1.CNhs12504.12238-129G6	15.95	4.47	2.55	2.55	4.47
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7	15.94	0.72	1.74	0.58	0.58
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3	15.90	1.77	0.95	1.63	1.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6	15.86	3.80	4.53	1.61	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1	15.85	2.82	3.04	2.17	1.30
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1	15.79	1.10	1.53	1.10	0.44
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8	15.77	2.39	1.80	1.20	1.00
Neurons, donor2.CNhs12726.11574-120E8	15.75	1.34	0.67	2.68	0.84
Basophils, donor1.CNhs12546.12241-129G9	15.73	0.79	2.36	1.18	0.39
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7	15.73	3.33	0.60	1.06	2.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6	15.70	1.53	3.45	1.15	0.38
amniotic membrane cells, donor3.CNhs12379.12237-129G5	15.67	5.22	0.92	4.30	8.60
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7	15.66	3.67	4.89	2.20	2.45
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4	15.62	2.21	3.32	1.60	1.11
Myoblast, donor2.CNhs11965.11322-117D8	15.62	2.26	1.44	1.64	1.64
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4	15.62	0.87	0.87	1.74	1.74
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9	15.61	3.41	0.72	2.33	5.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5	15.54	0.61	1.41	1.01	0.20
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4	15.54	0.83	2.34	1.10	0.41
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6	15.51	0.46	0.23	1.16	0.69
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1	15.49	6.05	6.42	1.89	3.02
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5	15.49	1.68	1.35	1.35	1.35
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5	15.42	0.00	0.93	1.49	0.19
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5	15.39	1.84	1.64	1.32	0.66
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6	15.34	2.32	2.79	1.16	1.16
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8	15.34	3.03	1.07	0.89	1.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6	15.31	1.86	1.86	0.46	1.86
temporal lobe, adult, pool1.CNhs10637.10031-101E4	15.30	2.52	1.97	1.09	1.16
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7	15.29	3.18	1.06	1.36	1.21
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2	15.26	1.91	1.53	1.14	3.43
Meningeal Cells, donor3.CNhs12731.11654-122E7	15.25	3.01	1.76	2.27	1.10
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4	15.21	1.18	1.86	0.79	0.59
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8	15.20	0.00	0.00	2.53	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4	15.19	3.48	2.85	3.16	1.58
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9	15.13	0.00	0.62	0.62	0.62
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3	15.10	5.52	6.26	2.58	4.05
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6	15.10	1.92	1.65	0.82	1.92
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3	15.09	3.77	5.51	1.74	2.32
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9	15.09	0.00	0.66	0.66	0.00
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2	15.04	2.29	1.47	1.63	2.94
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1	15.00	4.90	4.90	0.92	1.84
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7	15.00	0.42	1.90	0.63	0.63
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6	14.96	3.16	2.30	1.73	2.88
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5	14.90	1.64	0.98	0.98	1.64
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4	14.87	3.04	1.70	2.06	2.24
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2	14.87	2.53	0.84	1.52	1.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8	14.82	3.52	1.76	0.25	1.00
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8	14.80	1.50	0.64	1.93	1.72
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7	14.75	2.62	3.17	1.75	1.75
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9	14.67	3.12	0.00	1.87	0.94
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2	14.66	3.58	0.65	0.65	2.61
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7	14.64	1.16	0.39	2.70	1.93
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3	14.60	1.21	0.77	1.10	1.21
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9	14.58	3.09	1.37	0.86	0.69
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2	14.53	1.82	2.42	1.82	1.21
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9	14.49	2.56	4.26	1.28	2.13
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3	14.49	1.09	2.94	0.44	0.54
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2	14.48	2.16	1.69	0.92	1.85
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4	14.47	1.41	0.00	1.76	0.00
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8	14.43	0.00	1.44	1.44	4.33
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8	14.41	2.17	2.09	1.70	0.54
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3	14.36	2.92	0.27	0.53	1.33
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9	14.33	2.43	1.08	2.16	1.62
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7	14.26	0.89	1.34	0.78	0.67
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3	14.23	0.90	2.13	1.46	0.90
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1	14.16	1.57	0.92	1.57	1.31
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7	14.15	3.22	0.00	2.57	2.57
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3	14.14	2.12	0.85	1.27	1.98
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6	14.14	1.10	0.49	1.46	1.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3	14.13	3.99	0.61	16.28	6.14
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4	14.12	3.20	2.26	1.69	1.51
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5	14.09	2.52	1.76	1.26	2.26
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2	14.08	0.00	0.00	1.76	0.00
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3	14.07	2.56	5.11	0.64	1.92
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8	14.05	3.07	0.88	2.19	2.19
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5	14.03	3.10	3.48	1.55	0.97
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9	13.99	2.36	0.67	2.19	2.02
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8	13.93	4.93	3.06	1.02	3.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4	13.87	4.70	1.79	18.79	9.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6	13.85	1.54	1.15	1.15	3.08
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4	13.84	1.26	0.84	0.42	0.84
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4	13.83	2.46	0.19	0.95	1.14
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9	13.81	6.14	2.30	0.92	4.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9	13.79	2.21	1.43	1.76	1.10
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1	13.77	3.35	4.09	1.86	1.86
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8	13.76	4.39	4.39	0.60	2.39
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9	13.76	1.12	1.12	1.40	1.12
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1	13.76	1.71	1.71	1.58	0.12
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4	13.74	0.86	0.86	1.72	0.86
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3	13.68	1.65	1.81	3.96	1.98
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6	13.64	2.90	0.86	1.50	2.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1	13.55	5.06	4.31	1.62	2.90
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1	13.54	3.98	1.91	1.12	4.14
Mesothelial Cells, donor3.CNhs12012.11402-118D7	13.50	0.70	0.40	1.00	0.40
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6	13.48	0.78	1.17	0.59	0.59
retinoblastoma cell line:Y79.CNhs11267.10475-106I7	13.43	0.95	0.47	0.79	0.16
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3	13.42	1.99	1.49	0.99	1.49
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5	13.40	2.42	1.86	1.68	1.49
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2	13.39	2.71	1.31	1.15	1.64
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2	13.34	1.19	2.37	2.37	0.89
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5	13.33	1.82	1.14	2.73	0.91
Osteoblast, donor2.CNhs11385.11354-117H4	13.28	2.66	0.66	3.32	2.66
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9	13.27	0.25	1.23	0.00	0.25
Mesothelial Cells, donor1.CNhs10850.11247-116E5	13.26	0.90	0.90	0.30	1.81
liver, fetal, pool1.CNhs11798.10086-102B5	13.25	1.33	1.33	0.00	1.33
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8	13.24	2.13	3.07	1.18	1.18
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5	13.22	2.81	1.65	1.98	0.50
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5	13.20	3.57	0.47	0.78	2.17
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9	13.19	4.04	3.21	0.99	2.23
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2	13.17	2.45	0.61	0.61	2.45
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8	13.16	5.59	3.86	2.21	2.52
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5	13.15	1.94	0.30	1.05	1.20
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1	13.15	0.88	0.72	1.76	2.40
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2	13.11	4.86	3.88	5.10	4.13
migratory langerhans cells, donor3.CNhs13547.11903-125F4	13.09	1.64	1.47	0.98	0.65
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3	13.05	2.47	1.06	2.82	1.76
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1	13.01	2.17	1.21	2.65	1.69
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9	13.01	4.50	1.84	16.02	7.01
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3	13.01	0.70	0.70	1.54	0.42
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5	12.97	0.44	0.66	2.09	0.11
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6	12.91	4.52	2.58	3.23	3.87
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3	12.90	0.48	0.96	0.96	1.43
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8	12.87	1.53	0.92	1.23	2.45
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3	12.87	11.15	4.46	3.60	5.49
mature adipocyte, donor3.CNhs12560.12233-129G1	12.87	1.23	1.53	1.53	0.92
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9	12.85	1.53	1.62	0.27	0.72
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5	12.83	6.00	4.64	1.09	2.18
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2	12.80	3.93	0.91	1.31	3.12
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7	12.80	0.85	1.81	1.07	0.32
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7	12.79	1.53	2.05	3.07	4.09
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4	12.79	2.61	1.57	1.57	1.57
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3	12.76	0.00	2.32	0.00	2.32
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1	12.74	1.99	0.80	1.59	1.99
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3	12.69	0.70	0.70	1.41	1.41
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4	12.66	0.60	1.21	0.00	6.03
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6	12.60	5.10	0.30	1.80	2.10
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5	12.59	0.16	0.64	1.28	0.64
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6	12.59	2.52	1.14	1.37	2.52
melanoma cell line:G-361.CNhs11254.10465-106H6	12.56	1.43	0.29	1.14	1.14
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3	12.56	1.04	1.27	1.27	0.92
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4	12.54	2.87	1.04	1.31	0.78
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9	12.52	1.56	1.56	0.52	1.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8	12.52	1.57	1.04	1.57	0.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9	12.44	2.49	1.66	0.83	1.66
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3	12.42	2.07	1.03	2.07	1.03
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6	12.41	0.71	1.42	0.35	2.48
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5	12.36	1.77	0.59	1.77	0.78
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1	12.34	3.08	0.00	1.54	0.00
Meningeal Cells, donor1.CNhs11320.11493-119E8	12.33	1.23	0.90	0.56	1.35
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9	12.33	1.68	1.68	0.56	0.67
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8	12.24	0.21	0.21	0.21	1.05
liposarcoma cell line:SW 872.CNhs11851.10726-110A6	12.24	1.36	2.72	0.68	1.25
Meningeal Cells, donor2.CNhs12080.11573-120E7	12.21	1.31	1.31	0.44	2.62
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6	12.20	1.80	2.20	2.40	1.00
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3	12.19	3.57	1.49	0.89	1.04
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5	12.19	2.68	0.24	0.24	1.46
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3	12.16	2.66	2.53	1.77	2.41
immature langerhans cells, donor1.CNhs13537.11904-125F5	12.15	6.52	6.52	2.02	1.57
Mallassez-derived cells, donor2.CNhs13550.11929-125I3	12.09	3.19	0.84	2.02	2.18
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2	12.09	1.86	0.00	0.93	3.25
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5	12.08	2.01	0.81	1.21	2.42
Adipocyte - omental, donor3.CNhs12068.11475-119C8	12.07	2.68	0.00	0.00	2.68
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8	12.07	1.66	1.18	2.13	1.77
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2	12.05	1.72	1.43	0.86	2.01
Preadipocyte - omental, donor1.CNhs11065.11468-119C1	12.05	3.33	1.03	1.54	2.05
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7	12.04	3.59	3.84	1.54	2.31
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3	12.01	0.77	1.92	0.51	0.13
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2	11.99	1.71	1.33	0.76	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7	11.99	2.79	3.12	1.40	1.15
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7	11.94	2.08	0.52	0.52	1.04
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6	11.90	3.02	0.89	1.42	1.24
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9	11.87	1.41	3.53	1.41	1.27
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8	11.86	4.59	3.20	2.03	1.60
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3	11.83	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8	11.77	5.88	5.57	0.93	2.79
Mallassez-derived cells, donor3.CNhs13551.11930-125I4	11.77	1.28	1.42	1.56	1.28
Preadipocyte - omental, donor2.CNhs11902.11329-117E6	11.77	7.16	1.02	2.05	2.56
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5	11.77	0.78	0.78	0.00	0.78
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4	11.76	2.09	0.57	3.42	1.33
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3	11.71	0.90	0.60	0.60	0.00
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1	11.71	0.95	0.63	1.90	1.58
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6	11.70	2.09	1.60	0.62	1.60
migratory langerhans cells, donor1.CNhs13535.11901-125F2	11.69	1.36	1.36	0.78	0.97
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1	11.66	2.59	1.30	1.08	2.38
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3	11.65	4.44	0.55	0.55	1.11
Osteoblast, donor3.CNhs12036.11426-118G4	11.62	0.92	0.92	0.37	1.29
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6	11.53	1.00	1.50	1.50	1.00
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4	11.52	0.62	0.72	0.62	1.13
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5	11.47	0.00	0.96	1.91	1.91
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5	11.44	1.72	1.14	0.95	1.33
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5	11.43	3.36	1.34	0.00	3.36
Cardiac Myocyte, donor2.CNhs12350.11605-120I3	11.40	1.34	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3	11.36	3.91	0.71	3.55	3.20
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2	11.34	1.62	0.81	0.81	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8	11.33	3.78	0.34	1.72	1.37
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2	11.24	0.00	1.02	0.00	0.00
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8	11.23	1.87	1.40	0.47	0.47
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1	11.20	1.40	1.75	0.70	1.05
chorionic membrane cells, donor3.CNhs12380.12240-129G8	11.19	1.07	4.26	0.00	3.20
heart, adult, diseased, donor1.CNhs11758.10051-101G6	11.16	0.00	0.43	0.43	1.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9	11.12	1.16	2.33	1.94	0.65
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6	11.03	3.31	0.00	2.21	2.57
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1	11.02	4.55	1.20	1.20	2.88
myeloma cell line:PCM6.CNhs11258.10474-106I6	11.02	0.34	0.52	0.52	0.00
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9	11.00	2.70	1.74	2.51	1.54
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2	10.95	1.56	3.13	0.00	0.00
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6	10.91	1.09	0.82	1.36	0.27
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1	10.90	2.09	1.49	0.75	2.54
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1	10.89	0.00	0.00	3.27	1.09
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3	10.87	0.49	1.73	0.99	0.49
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3	10.81	2.20	1.65	1.65	2.56
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4	10.79	2.70	1.35	1.89	1.21
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7	10.75	0.68	1.35	0.93	0.85
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3	10.75	1.00	0.75	1.00	1.37
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4	10.74	1.90	0.00	1.26	1.26
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9	10.74	3.10	0.36	2.00	2.37
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9	10.73	1.93	0.83	3.85	2.75
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9	10.73	1.59	2.58	1.39	2.78
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1	10.69	1.03	1.03	0.00	0.00
CD34+ Progenitors, donor1.CNhs13227.11545-120B6	10.57	0.00	1.32	0.00	1.32
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6	10.54	1.47	2.21	0.25	0.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1	10.52	11.57	9.02	10.52	7.67
prostate cancer cell line:DU145.CNhs11260.10490-107B4	10.40	0.59	0.95	1.30	0.83
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6	10.34	4.72	6.74	0.45	2.92
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7	10.34	3.49	0.23	1.16	2.09
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2	10.29	1.47	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2	10.28	1.14	0.38	0.38	1.52
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1	10.27	0.00	0.00	0.00	1.58
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3	10.22	0.69	1.26	1.38	1.49
Myoblast, donor3.CNhs11908.11398-118D3	10.21	5.01	3.22	1.97	1.97
chorionic membrane cells, donor2.CNhs12506.12239-129G7	10.17	2.66	1.37	1.28	2.38
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5	10.15	2.34	1.98	1.08	1.26
Urothelial Cells, donor2.CNhs12091.11600-120H7	10.11	1.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9	10.10	3.03	1.01	1.35	2.69
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2	10.05	1.51	0.50	0.50	1.51
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6	10.00	1.19	0.51	1.53	1.53
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8	9.98	1.81	1.25	1.25	2.16
brain, fetal, pool1.CNhs11797.10085-102B4	9.98	0.00	0.00	2.00	0.00
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9	9.97	1.53	0.77	0.00	1.15
Mast cell - stimulated, donor1.CNhs11073.11487-119E2	9.85	5.42	1.97	0.99	0.00
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8	9.83	1.17	1.17	0.70	0.23
Preadipocyte - breast, donor2.CNhs11971.11328-117E5	9.82	3.09	1.12	0.84	0.28
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8	9.79	1.70	0.85	7.24	2.56
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9	9.75	3.98	2.59	1.79	2.59
glioblastoma cell line:T98G.CNhs11272.10485-107A8	9.69	1.43	1.22	2.75	0.61
mesothelioma cell line:No36.CNhs13074.10857-111G2	9.67	1.73	0.35	2.76	3.11
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4	9.64	2.00	0.91	0.91	1.64
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8	9.61	1.25	1.88	1.36	0.52
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1	9.61	0.00	0.00	1.60	0.00
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5	9.59	1.22	0.41	1.22	1.22
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1	9.52	1.95	1.71	0.73	1.71
prostate cancer cell line:PC-3.CNhs11243.10439-106E7	9.45	0.89	0.44	0.44	0.89
Melanocyte - light, donor2.CNhs11383.11351-117H1	9.38	0.00	0.00	0.00	1.17
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9	9.37	3.75	1.87	0.94	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2	9.36	2.85	0.81	1.63	3.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5	9.27	2.44	0.00	0.98	0.98
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5	9.24	0.77	0.87	0.58	0.38
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1	9.15	2.61	0.65	1.31	1.74
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6	9.14	1.31	1.31	0.98	1.96
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1	9.12	0.76	0.00	0.76	0.76
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8	9.04	1.13	0.00	1.13	0.00
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7	9.03	1.50	0.60	0.90	0.30
Adipocyte - omental, donor1.CNhs11054.11473-119C6	9.02	4.23	1.55	1.69	1.55
Pericytes, donor1.CNhs11317.11491-119E6	9.01	1.37	0.98	0.39	0.59
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7	9.00	0.62	0.93	0.93	1.24
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1	8.94	0.80	1.59	1.99	1.19
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6	8.94	3.08	0.62	0.77	1.85
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5	8.93	0.31	0.31	1.54	0.00
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9	8.91	0.88	1.69	0.48	0.24
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6	8.89	1.16	0.97	1.16	0.77
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2	8.89	2.22	1.11	0.00	1.11
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3	8.83	7.57	1.26	2.52	1.26
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5	8.78	0.49	0.00	0.49	0.49
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7	8.76	2.43	0.00	1.46	0.49
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5	8.74	0.36	0.00	0.73	0.00
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8	8.71	3.96	2.38	1.58	0.79
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6	8.71	1.67	0.93	1.11	0.74
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1	8.70	2.61	0.00	0.87	0.87
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7	8.62	3.32	1.99	2.65	0.00
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5	8.61	0.23	0.23	0.91	0.68
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3	8.57	2.35	2.45	1.12	1.94
Melanocyte - light, donor3.CNhs12033.11423-118G1	8.55	0.00	0.00	0.00	1.71
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3	8.54	1.90	0.95	0.00	0.95
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3	8.50	0.74	0.74	0.74	0.74
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5	8.46	0.63	0.31	0.31	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5	8.45	1.06	0.00	0.00	5.28
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8	8.41	0.00	0.00	0.00	2.80
Adipocyte - breast, donor2.CNhs11969.11327-117E4	8.35	3.85	1.07	1.28	1.50
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2	8.30	3.58	0.29	1.57	1.43
Preadipocyte - breast, donor1.CNhs11052.11467-119B9	8.19	3.23	2.73	1.74	0.50
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9	8.13	1.03	1.18	0.89	1.33
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1	8.04	1.34	0.00	1.34	0.67
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5	7.99	0.57	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2	7.99	3.80	3.40	0.40	1.60
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6	7.99	0.65	0.22	1.08	0.86
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2	7.96	1.14	0.00	1.14	1.14
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9	7.94	1.44	0.00	2.89	2.89
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3	7.90	0.51	1.02	0.25	0.25
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4	7.90	1.47	1.47	1.22	0.41
Pericytes, donor2.CNhs12079.11571-120E5	7.89	0.69	1.03	0.34	1.03
Preadipocyte - omental, donor3.CNhs12013.11403-118D8	7.88	4.34	2.73	1.13	1.93
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7	7.87	0.00	0.66	0.33	0.00
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9	7.85	0.87	0.87	1.74	0.87
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2	7.82	0.43	0.65	0.43	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1	7.80	1.30	0.72	0.72	0.72
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8	7.77	2.80	1.40	0.62	2.18
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7	7.67	1.53	0.00	0.00	3.07
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4	7.65	3.21	0.74	0.00	1.48
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7	7.64	0.95	0.32	0.00	0.32
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1	7.62	0.53	0.00	0.26	0.26
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2	7.59	0.38	0.00	0.38	1.14
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5	7.56	2.12	2.12	1.21	1.81
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4	7.55	1.68	1.26	0.42	1.26
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8	7.53	0.00	0.60	0.00	1.51
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2	7.53	0.54	1.26	1.26	1.08
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5	7.46	1.60	0.27	1.07	0.27
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4	7.31	1.46	1.46	1.46	0.00
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1	7.31	1.36	0.51	0.51	2.38
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8	7.29	0.56	2.80	1.68	1.68
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9	7.26	4.25	2.80	5.08	1.87
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8	7.22	1.80	0.20	0.80	2.21
leiomyoma cell line:15425.CNhs11724.10571-108B4	7.18	0.65	0.00	0.98	0.98
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9	7.11	2.09	1.25	1.25	2.09
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8	7.10	1.77	0.00	0.00	0.35
Myoblast, donor1.CNhs10870.11241-116D8	7.09	4.78	2.75	2.17	2.17
Urothelial Cells, donor3.CNhs12122.11681-122H7	7.09	0.44	0.00	0.00	0.44
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9	7.05	0.00	0.54	0.00	1.09
Adipocyte - omental, donor2.CNhs12067.11474-119C7	7.01	6.00	3.00	1.00	3.00
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9	7.00	1.10	0.37	0.74	1.66
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9	6.97	2.73	1.82	0.91	2.12
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4	6.97	2.79	0.70	0.00	1.39
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6	6.94	0.00	0.93	0.46	0.46
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8	6.82	0.00	0.62	0.00	0.93
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3	6.77	2.40	2.18	0.44	1.75
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8	6.74	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4	6.74	1.69	0.42	0.84	1.69
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2	6.65	0.83	0.00	0.00	0.83
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9	6.64	3.69	2.95	0.00	2.21
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3	6.62	0.87	1.39	0.00	0.87
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8	6.60	1.04	1.04	1.04	2.43
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2	6.59	1.58	0.26	0.53	1.06
Keratocytes, donor1.CNhs11337.11527-119I6	6.52	0.98	2.61	0.65	0.65
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2	6.47	2.16	0.00	0.00	0.72
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4	6.44	0.92	0.92	0.92	0.00
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4	6.40	2.13	0.00	0.00	3.20
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9	6.40	0.26	0.26	0.26	0.51
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3	6.17	0.82	1.65	2.47	0.41
Mesothelial Cells, donor2.CNhs12197.12156-128G5	6.10	1.74	0.00	2.61	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5	6.08	1.22	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2	6.07	1.10	1.10	0.00	1.10
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3	6.05	0.81	1.21	0.00	1.41
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9	5.91	1.56	0.31	1.24	1.56
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6	5.84	2.92	0.73	0.73	2.19
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8	5.76	0.82	0.00	0.00	0.82
Melanocyte - light, donor1.CNhs11303.11274-116H5	5.73	0.76	0.00	0.76	0.76
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6	5.65	1.13	0.00	1.13	0.00
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5	5.52	1.00	0.00	0.50	1.00
leiomyoma cell line:10964C.CNhs11722.10569-108B2	5.43	1.63	1.09	1.09	1.09
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1	5.30	1.06	1.41	0.71	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7	5.20	3.12	2.08	2.08	0.00
Sebocyte, donor2.CNhs11951.11301-117B5	5.20	0.00	1.30	0.00	0.00
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1	5.20	2.40	1.20	0.40	3.60
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3	5.19	0.65	1.30	0.00	0.00
Urothelial Cells, donor1.CNhs11334.11520-119H8	5.17	0.43	0.00	0.00	1.29
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6	5.14	0.77	0.26	0.51	0.51
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5	4.99	4.99	4.99	0.00	0.00
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4	4.96	0.90	1.35	0.45	0.45
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4	4.82	0.00	0.00	0.74	0.00
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6	4.64	1.07	0.00	0.71	1.43
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1	4.63	0.58	0.00	1.16	0.58
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6	4.61	0.54	0.27	1.08	0.27
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2	4.48	0.67	0.90	0.90	0.22
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2	4.45	2.97	0.00	1.48	1.48
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7	4.38	0.88	0.44	1.75	3.07
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3	4.30	0.86	0.00	0.86	3.44
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5	4.26	1.42	0.00	0.00	2.84
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6	4.23	0.47	0.00	0.94	0.47
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6	4.19	0.70	0.70	1.40	0.00
Keratocytes, donor2.CNhs12095.11607-120I5	4.16	2.08	0.00	1.04	0.00
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7	4.12	1.46	1.20	0.27	0.40
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7	3.98	0.80	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3	3.92	1.57	0.00	1.57	2.35
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1	3.73	0.53	1.06	1.06	1.06
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7	3.69	0.74	0.49	0.74	0.74
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8	3.66	0.56	0.56	0.56	1.13
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3	3.65	0.81	0.41	1.22	0.61
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8	3.64	1.01	1.21	0.40	0.61
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4	3.49	0.87	1.31	0.87	0.44
leiomyoma cell line:15242A.CNhs11723.10570-108B3	3.46	0.86	0.86	0.86	0.00
Sebocyte, donor1.CNhs10847.11220-116B5	3.45	0.00	0.57	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4	3.17	0.00	1.59	0.00	0.00
Adipocyte - breast, donor1.CNhs11051.11376-118A8	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7	0.00	0.00	0.00	0.00	0.00

Showing 1 to 889 of 889 entries

0

20

40

60

80

100

p1@SENP6
p2@SENP6
p3@SENP6
p4@SENP6
p5@SENP6

• Click each plot point to find sample in table

ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner <br>Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><br><br>link to source dataset.<br>data

---

No analysis results for this cluster

Details<b>Summary:</b>It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq.<br><br>links to source dataset.<br>human <br>mouse

---

GeneID:	26054
LocusTag:	RP1-134M13.1
chromosome:	6
map location:	6q13-q14.3
type of gene:	protein-coding
Symbol from nomenclature authority:	SENP6
Full name from nomenclature authority:	SUMO1/sentrin specific peptidase 6
Nomenclature status:	O
Other designations:	2810017C20Rik, SUMO-1-specific protease 1, SUMO1/sentrin specific protease 6, sentrin-specific protease 6, sentrin/SUMO-specific protease SENP6, 2810017C20Rik;;SUMO-1-specific protease 1;;SUMO1/sentrin specific protease 6;;sentrin-specific protease 6;;sentrin/SUMO-specific protease SENP6
Modification date:	08.01.2012